Author: Paul Govern
Reminders for clinicians improve prescribing for high cholesterol
Mar. 23, 2023—A Vanderbilt study found that automated targeted reminders for clinicians helped increase prescribing of high intensity statins for patients with various atherosclerotic cardiovascular disease diagnoses, including coronary or peripheral artery disease and ischemic stroke.
Survey finds patients value immediate access to test results
Mar. 22, 2023—A survey sent to more than 43,000 patients living in several states around the country finds that 96% of patients who use patient web portals prefer immediate online access to their clinical test results.
Online course seeks to address opioid deaths in adolescents
Mar. 9, 2023—Vanderbilt is providing a short online course for educators that seeks to address opioid overdose deaths among adolescents.
Sex counts in the brain as seasons change
Mar. 2, 2023—Photoperiod, or length of day, has sex-specific impacts on dopamine dynamics in the brain, offering insights into sex differences in neuropsychiatric disorders, Vanderbilt researchers report.
Global study tracks brain infection in people with HIV
Mar. 2, 2023—A Vanderbilt study is shedding new light on the incidence and mortality of cryptococcal meningitis among people with HIV
Medical Center help desk adds automated chat services
Mar. 2, 2023—Vanderbilt University Medical Center’s information technology help desk has an online component called Pegasus, which has added an automated chat feature to help serve VUMC employees, patients and families seeking technical assistance.
NIH grant supports TB research network in Brazil
Feb. 23, 2023—The National Institutes of Health has awarded a five-year, $5 million grant to Vanderbilt University Medical Center for continued support of the Brazil Regional Prospective Observational Research in Tuberculosis network, or RePORT-Brazil.
Machine learning aids injury prevention in cardiac cath labs
Feb. 2, 2023— by Paul Govern Acute kidney injury, or AKI, is a common complication of cardiac catheterization, posing higher costs, longer hospital stays and increased short-term and long-term mortality risk. In a large, randomized trial conducted over a period of 18 months at 19 medical centers of the Veterans Health Administration, a quality improvement implementation trial...
Vaccine effectiveness research continues to grow
Jan. 26, 2023—Vanderbilt's participation in vaccine effectiveness research continues to grow, with the Medical Center playing critical roles in several networks focused on surveillance of vaccine-preventable respiratory diseases.
Machine learning predicts delirium
Jan. 23, 2023—Using machine learning based on electronic health records of ICU patients predicted new-onset delirium with 82% sensitivity, Vanderbilt researchers found.
Dooley honored by Treatment Action Group
Dec. 15, 2022—Vanderbilt's Kelly Dooley, MD, PhD, MPH, recently received the Research in Action Award from the Treatment Action Group (TAG).
Surgical risk persists for patients who’ve had COVID
Dec. 14, 2022—Vanderbilt researchers report that the trend of decreasing postoperative risk for people who have had COVID persists longer than previously known, for as long as 13 months after COVID.
